The Mondial Research Group offers a series of annual events, developed in-house and with our strategic partners from within the biotechnology and pharmaceutical community. It is our goal to help improve the productivity, accelerate the pace, and reduce the cost of pharmaceutical research and development, as well as highlight areas for technological advances within the life sciences.
The conference is scheduled for the 24th and 25th of January 2013 in Brussels, Belgium.
Topics of Discussion include:
- ADME Optimisation for Drug Design/Discovery
- PK/PD
- High Content Screening
- Biobased Cellular Toxicity Assays
- Metabolomics
- MIP-DILI | IMI
- IPS-derived Primary Cultures for Toxicity Assays
- In Vitro QT Prolongation Assays with Cardiomyocytes
- Genotoxicity
- Biomarker Identification with Toxicogenomics
- New Therapeutic Targets in Drug Design/Discovery
- Pharmacogenomics and Drug Safety
- Regulatory Issues in ADME
- A Novel Human Hepatocyte Assay for Accurate Prediction of Severe DILI Drugs
- Translational Investigation of Drug Disposition in Children
There will be an open exhibition with select industry solution providers for both days of the conference.
Early Bird Registration: If you register online before October 31, 2012 you may attend the 2-day conference for just £999 GBP/person.
For more information visit the website.
Contact:
Cristina C. Lungu
Event Coordinator/Business Development Manager
Mondial Research Group
tel +44 20 8144 7170
fax +40 21 223 6500
cristinah[at]mondialresearchgroup.com